HPR125 Analysis of IPT Developed for the New Medicines and Indications Authorized by the European Commission During the 2021-2023 Period
Abstract
Authors
J Armengol J. Costa-Samarra M Cuesta J Jara N. López-Martínez J. Sánchez-Martín